Clinical Study of TCR-like CAR-T Cell Targeted MSLN in the Treatment of Ovarian Cancer

PHASE1/PHASE2Active, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 7, 2023

Primary Completion Date

May 16, 2026

Study Completion Date

May 16, 2026

Conditions

Safety and Efficacy of TCR-like CAR-T

Interventions

BIOLOGICAL

TCR-like CAR-T

intravenous drip of TCR-like CAR-T with indicated doses

Trial Locations (1)

Zhongda hospital, Nanjing

All Listed Sponsors

lead

Zhongda Hospital

OTHER

NCT05963100 - Clinical Study of TCR-like CAR-T Cell Targeted MSLN in the Treatment of Ovarian Cancer | Biotech Hunter | Biotech Hunter